Letrozole after ovarian stimulation in egg donors
Part of Women’s health & pregnancy clinical trials.
This study tests whether giving the drug letrozole after ovarian stimulation can help egg donors. The goal is to see if it reduces the risk of ovarian hyperstimulation syndrome, a side effect that can happen after donating eggs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be donating eggs and have at least 18 follicles measuring 11 mm or larger on your last ultrasound before egg retrieval.
- You cannot be currently taking part in another clinical study that could interfere with this one.
- You must not have a known allergy to letrozole.
- You must not have a known lactose intolerance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.
This study tests if a medicine called letrozole can help prepare the lining of the womb for a frozen embryo transfer. It may be an option for women under 40 who have had limited previous IVF cycles.
This trial compares two ways to prepare the uterus for a frozen embryo transfer: using the hormone letrozole or a standard artificial cycle. The goal is to see which approach works better for people with irregular periods.
This study tests whether taking letrozole after laparoscopic ovarian cyst surgery can lower the chance that an endometrioma (a type of ovarian endometriosis cyst) comes back. It may help some people reduce recurrence after the cyst is removed.
This trial uses a hormone called progesterone as a trigger for ovulation in egg donors, instead of the usual hCG. It may help lower the risk of ovarian hyperstimulation syndrome while still producing mature eggs for donation.
This trial tests whether taking progesterone after a type of fertility treatment called IUI can improve success rates. The study focuses on people who are using a drug called letrozole to stimulate the ovaries.
Hear when a new Luteinised Follicular Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.